undamentalytics Newsletter
Sign in

Therapeuticsmd, Inc. balance sheet

At the end of fiscal 2025, Therapeuticsmd, Inc. had total assets of $37.7m, total liabilities of $10.8m and shareholders' equity of $26.9m. It held $7.5m in cash against $0 of debt: net cash of $7.5m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents0————1321271621618065494579
Receivables012235411243236—————
Inventory121111131288—————
Total current assets155956711391401872081281195512121416
Total assets166259741421432122661821699043393838
Accounts payable0226374231921320000
Total current liabilities34711111513415359253477555
Short-term debt——————————188—————
Long-term debt—4—————731952380—————
Total debt04—000073195238188—0000
Total liabilities3771111—131142573062635514111110
Shareholders' equity−2−1554863127130989−124−943529272727
Net debt (negative = net cash)−0————−132−127−8834157123−49−4−5−7−9
Shares outstanding——————————9m9m12m12m12m12m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: EYPT vs TXMDCPHI vs TXMDNTRB vs TXMD

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Therapeuticsmd, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Therapeuticsmd, Inc.